DLBCL ACTIVATED B-CELL TYPE

Clinical trials for DLBCL ACTIVATED B-CELL TYPE explained in plain language.

Never miss a new study

Get alerted when new DLBCL ACTIVATED B-CELL TYPE trials appear

Sign up with your email to follow new studies for DLBCL ACTIVATED B-CELL TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test new Two-Pronged attack on tough blood cancers

Disease control Recruiting now

This is a small, early-stage study for adults with B-cell leukemia or lymphoma that has come back or not responded to other treatments. The goal is to test the safety of a new two-step approach. First, patients receive a targeted radioactive drug (131-I apamistamab), followed by …

Matched conditions: DLBCL ACTIVATED B-CELL TYPE

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 06, 2026 15:37 UTC

DLBCL ACTIVATED B-CELL TYPE

Get alerted when new DLBCL ACTIVATED B-CELL TYPE trials appear

Scientists test new Two-Pronged attack on tough blood cancers